Erin Graves | Senior Director of Corporate Communications and Investor Relations |
Mark Goldsmith | Chairman and Chief Executive Officer |
Jack Anders | Chief Financial Officer |
Steve Kelsey | President of Research & Development |
Marc Frahm | TD Cowen |
Faisal Khushid | Leerink Partners |
Jay Olson | Oppenheimer |
Ami Fadia | Needham |
Alec Stranahan | Bank of America |
Ben Burnett | Stifel |
Good day and thank you for standing by. Welcome to Revolution Medicine's Second Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.